Live Breaking News & Updates on News Ratings For Rocket Pharmaceuticals Daily

Stay updated with breaking news from News ratings for rocket pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avoro Capital Advisors LLC Increases Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

Avoro Capital Advisors LLC increased its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,260,900 shares of the biotechnology company’s stock after buying an additional 10,900 shares during the quarter. […] ....

New York , United States , William Blair , Gaurav Shah , John Militello , News Ratings For Rocket Pharmaceuticals Daily , Avoro Capital Advisors , Principal Financial Group Inc , Rocket Pharmaceuticals , Rocket Pharmaceuticals Inc , Jpmorgan Chase Co , Cantor Fitzgerald , York State Common Retirement Fund , Rocket Pharmaceuticals Company Profile , Torray Investment Partners , Goldman Sachs Group , Quarter For Rocket Pharmaceuticals , Tower Research Capital , Needham Company , Insider Activity At Rocket Pharmaceuticals , Securities Exchange Commission , Rocket Pharmaceuticals Stock Performance , Free Report , Capital Advisors , Financial Group , Investment Partners ,

Head-To-Head Analysis: Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and Rocket Pharmaceuticals (NASDAQ:RCKT)

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Rocket Pharmaceuticals […] ....

United States , New Jersey , Medioambientalesy Tecnol , Investigacion Biomedica , Investigaciones Energ , Fundacion Jimenez Diaz , Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Regents Of The University California , Rocket Pharmaceuticals Inc , Regenxbio Inc , Get Free Report , Calliditas Therapeutics , Given Rocket Pharmaceutical , Centro De Investigaciones Energ , Centro De Investigacion Biomedica En Red , Fundacion Instituto , Sanitaria Fundacion Jimenez Diaz , Rocket Pharmaceuticals Daily ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […] ....

United States , John Militello , Mark Andrew White , Rocket Pharmaceuticals Inc , Allspring Global Investments Holdings , Torray Investment Partners , Rocket Pharmaceuticals Company Profile , Analyst Recommendations For Rocket Pharmaceuticals , Jpmorgan Chase Co , News Ratings For Rocket Pharmaceuticals Daily , Institutional Investors Weigh In On Rocket Pharmaceuticals , Rocket Pharmaceuticals , Rocket Pharmaceuticals Stock Performance , Securities Exchange Commission , Principal Financial Group Inc , Needham Company , Cantor Fitzgerald , Get Free Report , Exchange Commission , Global Investments Holdings , Financial Group , Investment Partners , Teacher Retirement System , Retirement System , Get Free , Rocket Pharmaceuticals Daily ,

John Militello Sells 1,079 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Stock

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) insider John Militello sold 1,079 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $23.35, for a total transaction of $25,194.65. Following the completion of the sale, the insider now owns 53,327 shares of the […] ....

New Zealand General , New Zealand , John Militello , Wellington Management Group , News Ratings For Rocket Pharmaceuticals Daily , Rocket Pharmaceuticals , Pricet Rowe Associates Inc , Goldman Sachs Group , Rocket Pharmaceuticals Inc , Quarter For Rocket Pharmaceuticals , Rocket Pharmaceuticals Company Profile , Vanguard Group Inc , Institutional Trading Of Rocket Pharmaceuticals , Securities Exchange Commission , Janus Henderson Group , Rocket Pharmaceuticals Stock Performance , Westfield Capital Management Co , Needham Company , Cantor Fitzgerald , Get Free Report , Exchange Commission , Management Group , Capital Management , Henderson Group , Rocket Pharmaceuticals Daily ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) General Counsel Martin Wilson Sells 1,048 Shares

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) General Counsel Martin Wilson sold 1,048 shares of Rocket Pharmaceuticals stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.35, for a total transaction of $24,470.80. Following the completion of the transaction, the general counsel now directly owns 65,762 […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Martin Wilson , Cantor Fitzgerald , Jpmorgan Chase Co , Needham Company , Asset Management North America Corp , Rocket Pharmaceuticals Stock Performance , York Mellon Corp , Allspring Global Investments Holdings , Quarter For Rocket Pharmaceuticals , Rocket Pharmaceuticals Inc , Securities Exchange Commission , Institutional Trading Of Rocket Pharmaceuticals , Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Get Free Report , General Counsel Martin Wilson , Exchange Commission , New York Mellon Corp , Kantonalbank Zurich Cantonalbank , Global Investments Holdings , Retirement System , Management North America , Rocket Pharmaceuticals Daily ,